Clinical observations show that IGFBP5 is associated with the metastatic tumor phenotype in breast cancer, thus IGFBP5 is a poor prognostic factor and may serve as a target for therapeutic development [18,19,25,26]. The gene discussed is IGFBP5; the disease is metastatic neoplasm.